nodes	percent_of_prediction	percent_of_DWPC	metapath
Chlorpropamide—SLC22A6—Stavudine—acquired immunodeficiency syndrome	0.0918	0.112	CbGbCtD
Chlorpropamide—SLC22A6—Didanosine—acquired immunodeficiency syndrome	0.0696	0.085	CbGbCtD
Chlorpropamide—SLC22A6—Zidovudine—acquired immunodeficiency syndrome	0.0365	0.0447	CbGbCtD
Chlorpropamide—CYP2C19—Efavirenz—acquired immunodeficiency syndrome	0.0327	0.0399	CbGbCtD
Chlorpropamide—CYP2C19—Lopinavir—acquired immunodeficiency syndrome	0.0307	0.0375	CbGbCtD
Chlorpropamide—SLC22A6—Lamivudine—acquired immunodeficiency syndrome	0.0283	0.0345	CbGbCtD
Chlorpropamide—CYP2C19—Amprenavir—acquired immunodeficiency syndrome	0.0278	0.0339	CbGbCtD
Chlorpropamide—CYP2C19—Delavirdine—acquired immunodeficiency syndrome	0.0278	0.0339	CbGbCtD
Chlorpropamide—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.0272	0.0332	CbGbCtD
Chlorpropamide—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.0255	0.0312	CbGbCtD
Chlorpropamide—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.0255	0.0312	CbGbCtD
Chlorpropamide—ABCB1—Lopinavir—acquired immunodeficiency syndrome	0.0248	0.0303	CbGbCtD
Chlorpropamide—CYP2C19—Indinavir—acquired immunodeficiency syndrome	0.024	0.0293	CbGbCtD
Chlorpropamide—CYP2C19—Nelfinavir—acquired immunodeficiency syndrome	0.0233	0.0284	CbGbCtD
Chlorpropamide—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.0231	0.0282	CbGbCtD
Chlorpropamide—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.0231	0.0282	CbGbCtD
Chlorpropamide—ABCB1—Amprenavir—acquired immunodeficiency syndrome	0.0224	0.0274	CbGbCtD
Chlorpropamide—CYP2C19—Saquinavir—acquired immunodeficiency syndrome	0.021	0.0257	CbGbCtD
Chlorpropamide—CYP2C19—Ritonavir—acquired immunodeficiency syndrome	0.021	0.0257	CbGbCtD
Chlorpropamide—CYP2C19—Zidovudine—acquired immunodeficiency syndrome	0.0202	0.0247	CbGbCtD
Chlorpropamide—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.0199	0.0244	CbGbCtD
Chlorpropamide—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.0193	0.0236	CbGbCtD
Chlorpropamide—ABCB1—Indinavir—acquired immunodeficiency syndrome	0.0193	0.0236	CbGbCtD
Chlorpropamide—ABCB1—Nelfinavir—acquired immunodeficiency syndrome	0.0188	0.0229	CbGbCtD
Chlorpropamide—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.0175	0.0214	CbGbCtD
Chlorpropamide—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.0175	0.0214	CbGbCtD
Chlorpropamide—ABCB1—Ritonavir—acquired immunodeficiency syndrome	0.017	0.0208	CbGbCtD
Chlorpropamide—ABCB1—Saquinavir—acquired immunodeficiency syndrome	0.017	0.0208	CbGbCtD
Chlorpropamide—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.0168	0.0205	CbGbCtD
Chlorpropamide—ABCB1—Zidovudine—acquired immunodeficiency syndrome	0.0163	0.0199	CbGbCtD
Chlorpropamide—ABCB1—Lamivudine—acquired immunodeficiency syndrome	0.0126	0.0154	CbGbCtD
Chlorpropamide—Proctocolitis—Ritonavir—acquired immunodeficiency syndrome	0.00505	0.0332	CcSEcCtD
Chlorpropamide—Alcohol intolerance—Efavirenz—acquired immunodeficiency syndrome	0.00454	0.0298	CcSEcCtD
Chlorpropamide—Alcohol intolerance—Delavirdine—acquired immunodeficiency syndrome	0.00434	0.0285	CcSEcCtD
Chlorpropamide—Alcohol intolerance—Ritonavir—acquired immunodeficiency syndrome	0.00401	0.0264	CcSEcCtD
Chlorpropamide—Drug interaction—Didanosine—acquired immunodeficiency syndrome	0.00234	0.0154	CcSEcCtD
Chlorpropamide—Eruption—Efavirenz—acquired immunodeficiency syndrome	0.00234	0.0154	CcSEcCtD
Chlorpropamide—Drug interaction—Nevirapine—acquired immunodeficiency syndrome	0.00211	0.0139	CcSEcCtD
Chlorpropamide—Drug interaction—Zidovudine—acquired immunodeficiency syndrome	0.00177	0.0116	CcSEcCtD
Chlorpropamide—Aplastic anaemia—Abacavir—acquired immunodeficiency syndrome	0.00175	0.0115	CcSEcCtD
Chlorpropamide—Hypoglycaemia—Didanosine—acquired immunodeficiency syndrome	0.00162	0.0106	CcSEcCtD
Chlorpropamide—Fluid retention—Zidovudine—acquired immunodeficiency syndrome	0.00156	0.0102	CcSEcCtD
Chlorpropamide—Aplastic anaemia—Zidovudine—acquired immunodeficiency syndrome	0.00154	0.0101	CcSEcCtD
Chlorpropamide—CYP2C19—blood plasma—acquired immunodeficiency syndrome	0.00151	0.0532	CbGeAlD
Chlorpropamide—Dermatitis exfoliative—Nevirapine—acquired immunodeficiency syndrome	0.0015	0.00989	CcSEcCtD
Chlorpropamide—Drug interaction—Delavirdine—acquired immunodeficiency syndrome	0.00149	0.00978	CcSEcCtD
Chlorpropamide—Jaundice cholestatic—Ritonavir—acquired immunodeficiency syndrome	0.00145	0.00955	CcSEcCtD
Chlorpropamide—Hypoglycaemia—Nelfinavir—acquired immunodeficiency syndrome	0.00141	0.00926	CcSEcCtD
Chlorpropamide—Drug interaction—Ritonavir—acquired immunodeficiency syndrome	0.00138	0.00904	CcSEcCtD
Chlorpropamide—Drug interaction—Saquinavir—acquired immunodeficiency syndrome	0.00132	0.0087	CcSEcCtD
Chlorpropamide—Haemolytic anaemia—Zidovudine—acquired immunodeficiency syndrome	0.00132	0.00867	CcSEcCtD
Chlorpropamide—Drug interaction—Lamivudine—acquired immunodeficiency syndrome	0.00126	0.0083	CcSEcCtD
Chlorpropamide—Haemolytic anaemia—Indinavir—acquired immunodeficiency syndrome	0.00123	0.00807	CcSEcCtD
Chlorpropamide—Eosinophilia—Nevirapine—acquired immunodeficiency syndrome	0.00121	0.00799	CcSEcCtD
Chlorpropamide—PTGS1—endothelium—acquired immunodeficiency syndrome	0.00121	0.0424	CbGeAlD
Chlorpropamide—CYP2C9—blood plasma—acquired immunodeficiency syndrome	0.00117	0.0412	CbGeAlD
Chlorpropamide—Agranulocytosis—Didanosine—acquired immunodeficiency syndrome	0.00114	0.00746	CcSEcCtD
Chlorpropamide—Erythema multiforme—Amprenavir—acquired immunodeficiency syndrome	0.00113	0.00745	CcSEcCtD
Chlorpropamide—KCNJ11—lymphoid tissue—acquired immunodeficiency syndrome	0.00111	0.039	CbGeAlD
Chlorpropamide—Haemolytic anaemia—Delavirdine—acquired immunodeficiency syndrome	0.00111	0.00729	CcSEcCtD
Chlorpropamide—Dermatitis exfoliative—Efavirenz—acquired immunodeficiency syndrome	0.00111	0.00729	CcSEcCtD
Chlorpropamide—Aplastic anaemia—Lamivudine—acquired immunodeficiency syndrome	0.0011	0.00723	CcSEcCtD
Chlorpropamide—PTGS1—blood plasma—acquired immunodeficiency syndrome	0.00107	0.0376	CbGeAlD
Chlorpropamide—Dermatitis exfoliative—Delavirdine—acquired immunodeficiency syndrome	0.00106	0.00698	CcSEcCtD
Chlorpropamide—Agranulocytosis—Nevirapine—acquired immunodeficiency syndrome	0.00102	0.00671	CcSEcCtD
Chlorpropamide—Hyponatraemia—Delavirdine—acquired immunodeficiency syndrome	0.00101	0.00661	CcSEcCtD
Chlorpropamide—Haemolytic anaemia—Saquinavir—acquired immunodeficiency syndrome	0.000988	0.00649	CcSEcCtD
Chlorpropamide—Dermatitis exfoliative—Ritonavir—acquired immunodeficiency syndrome	0.000982	0.00645	CcSEcCtD
Chlorpropamide—Pancytopenia—Zidovudine—acquired immunodeficiency syndrome	0.000978	0.00643	CcSEcCtD
Chlorpropamide—SLC15A1—digestive system—acquired immunodeficiency syndrome	0.000966	0.0339	CbGeAlD
Chlorpropamide—Erythema multiforme—Nevirapine—acquired immunodeficiency syndrome	0.000929	0.0061	CcSEcCtD
Chlorpropamide—ABCC8—spinal cord—acquired immunodeficiency syndrome	0.000927	0.0325	CbGeAlD
Chlorpropamide—Hypoglycaemia—Saquinavir—acquired immunodeficiency syndrome	0.000914	0.006	CcSEcCtD
Chlorpropamide—Erythema multiforme—Nelfinavir—acquired immunodeficiency syndrome	0.000899	0.00591	CcSEcCtD
Chlorpropamide—Hyponatraemia—Saquinavir—acquired immunodeficiency syndrome	0.000895	0.00588	CcSEcCtD
Chlorpropamide—Erythema multiforme—Abacavir—acquired immunodeficiency syndrome	0.000883	0.00581	CcSEcCtD
Chlorpropamide—Hypoglycaemia—Lamivudine—acquired immunodeficiency syndrome	0.000872	0.00573	CcSEcCtD
Chlorpropamide—SLC15A2—retina—acquired immunodeficiency syndrome	0.00086	0.0302	CbGeAlD
Chlorpropamide—Pancytopenia—Efavirenz—acquired immunodeficiency syndrome	0.000859	0.00565	CcSEcCtD
Chlorpropamide—Eosinophilia—Delavirdine—acquired immunodeficiency syndrome	0.000857	0.00563	CcSEcCtD
Chlorpropamide—Agranulocytosis—Zidovudine—acquired immunodeficiency syndrome	0.000857	0.00563	CcSEcCtD
Chlorpropamide—SLC15A1—vagina—acquired immunodeficiency syndrome	0.000853	0.0299	CbGeAlD
Chlorpropamide—Leukopenia—Didanosine—acquired immunodeficiency syndrome	0.000851	0.00559	CcSEcCtD
Chlorpropamide—KCNJ11—nervous system—acquired immunodeficiency syndrome	0.000848	0.0298	CbGeAlD
Chlorpropamide—Photosensitivity reaction—Efavirenz—acquired immunodeficiency syndrome	0.000826	0.00543	CcSEcCtD
Chlorpropamide—Pancytopenia—Delavirdine—acquired immunodeficiency syndrome	0.000822	0.0054	CcSEcCtD
Chlorpropamide—KCNJ11—central nervous system—acquired immunodeficiency syndrome	0.000817	0.0287	CbGeAlD
Chlorpropamide—Anorexia—Amprenavir—acquired immunodeficiency syndrome	0.000811	0.00533	CcSEcCtD
Chlorpropamide—ABCC8—nervous system—acquired immunodeficiency syndrome	0.000781	0.0274	CbGeAlD
Chlorpropamide—Erythema multiforme—Zidovudine—acquired immunodeficiency syndrome	0.000779	0.00512	CcSEcCtD
Chlorpropamide—Thrombocytopenia—Didanosine—acquired immunodeficiency syndrome	0.00076	0.00499	CcSEcCtD
Chlorpropamide—ABCC8—central nervous system—acquired immunodeficiency syndrome	0.000752	0.0264	CbGeAlD
Chlorpropamide—Leukopenia—Nelfinavir—acquired immunodeficiency syndrome	0.000741	0.00487	CcSEcCtD
Chlorpropamide—Decreased appetite—Amprenavir—acquired immunodeficiency syndrome	0.00074	0.00486	CcSEcCtD
Chlorpropamide—Anorexia—Didanosine—acquired immunodeficiency syndrome	0.00074	0.00486	CcSEcCtD
Chlorpropamide—Leukopenia—Stavudine—acquired immunodeficiency syndrome	0.000739	0.00486	CcSEcCtD
Chlorpropamide—Gastrointestinal disorder—Amprenavir—acquired immunodeficiency syndrome	0.000735	0.00483	CcSEcCtD
Chlorpropamide—Pancytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000732	0.00481	CcSEcCtD
Chlorpropamide—Photosensitivity reaction—Ritonavir—acquired immunodeficiency syndrome	0.000731	0.0048	CcSEcCtD
Chlorpropamide—Leukopenia—Abacavir—acquired immunodeficiency syndrome	0.000728	0.00478	CcSEcCtD
Chlorpropamide—Erythema multiforme—Indinavir—acquired immunodeficiency syndrome	0.000725	0.00476	CcSEcCtD
Chlorpropamide—Photosensitivity reaction—Saquinavir—acquired immunodeficiency syndrome	0.000703	0.00462	CcSEcCtD
Chlorpropamide—Pancytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000698	0.00459	CcSEcCtD
Chlorpropamide—SLC22A6—brain—acquired immunodeficiency syndrome	0.000686	0.0241	CbGeAlD
Chlorpropamide—Erythema multiforme—Efavirenz—acquired immunodeficiency syndrome	0.000685	0.0045	CcSEcCtD
Chlorpropamide—Thrombocytopenia—Nevirapine—acquired immunodeficiency syndrome	0.000683	0.00449	CcSEcCtD
Chlorpropamide—Dyspepsia—Didanosine—acquired immunodeficiency syndrome	0.000683	0.00449	CcSEcCtD
Chlorpropamide—Decreased appetite—Didanosine—acquired immunodeficiency syndrome	0.000675	0.00443	CcSEcCtD
Chlorpropamide—Anorexia—Nevirapine—acquired immunodeficiency syndrome	0.000665	0.00437	CcSEcCtD
Chlorpropamide—Thrombocytopenia—Nelfinavir—acquired immunodeficiency syndrome	0.000662	0.00435	CcSEcCtD
Chlorpropamide—Thrombocytopenia—Stavudine—acquired immunodeficiency syndrome	0.00066	0.00434	CcSEcCtD
Chlorpropamide—Erythema multiforme—Delavirdine—acquired immunodeficiency syndrome	0.000655	0.00431	CcSEcCtD
Chlorpropamide—Thrombocytopenia—Abacavir—acquired immunodeficiency syndrome	0.00065	0.00427	CcSEcCtD
Chlorpropamide—KCNJ11—brain—acquired immunodeficiency syndrome	0.000648	0.0228	CbGeAlD
Chlorpropamide—Anorexia—Nelfinavir—acquired immunodeficiency syndrome	0.000644	0.00423	CcSEcCtD
Chlorpropamide—Leukopenia—Zidovudine—acquired immunodeficiency syndrome	0.000642	0.00422	CcSEcCtD
Chlorpropamide—Anorexia—Stavudine—acquired immunodeficiency syndrome	0.000642	0.00422	CcSEcCtD
Chlorpropamide—ABCB1—blood plasma—acquired immunodeficiency syndrome	0.000634	0.0222	CbGeAlD
Chlorpropamide—Anorexia—Abacavir—acquired immunodeficiency syndrome	0.000633	0.00416	CcSEcCtD
Chlorpropamide—KCNJ11—lymph node—acquired immunodeficiency syndrome	0.000627	0.022	CbGeAlD
Chlorpropamide—Agranulocytosis—Lamivudine—acquired immunodeficiency syndrome	0.000612	0.00402	CcSEcCtD
Chlorpropamide—Decreased appetite—Nevirapine—acquired immunodeficiency syndrome	0.000607	0.00399	CcSEcCtD
Chlorpropamide—Erythema multiforme—Ritonavir—acquired immunodeficiency syndrome	0.000606	0.00398	CcSEcCtD
Chlorpropamide—Gastrointestinal disorder—Nevirapine—acquired immunodeficiency syndrome	0.000602	0.00396	CcSEcCtD
Chlorpropamide—Pruritus—Amprenavir—acquired immunodeficiency syndrome	0.000602	0.00396	CcSEcCtD
Chlorpropamide—ABCC8—brain—acquired immunodeficiency syndrome	0.000597	0.021	CbGeAlD
Chlorpropamide—Dyspepsia—Nelfinavir—acquired immunodeficiency syndrome	0.000595	0.00391	CcSEcCtD
Chlorpropamide—Dyspepsia—Stavudine—acquired immunodeficiency syndrome	0.000593	0.0039	CcSEcCtD
Chlorpropamide—Decreased appetite—Nelfinavir—acquired immunodeficiency syndrome	0.000587	0.00386	CcSEcCtD
Chlorpropamide—Decreased appetite—Stavudine—acquired immunodeficiency syndrome	0.000586	0.00385	CcSEcCtD
Chlorpropamide—Gastrointestinal disorder—Nelfinavir—acquired immunodeficiency syndrome	0.000583	0.00383	CcSEcCtD
Chlorpropamide—Erythema multiforme—Saquinavir—acquired immunodeficiency syndrome	0.000583	0.00383	CcSEcCtD
Chlorpropamide—CYP2C19—digestive system—acquired immunodeficiency syndrome	0.000583	0.0204	CbGeAlD
Chlorpropamide—Diarrhoea—Amprenavir—acquired immunodeficiency syndrome	0.000582	0.00383	CcSEcCtD
Chlorpropamide—Gastrointestinal disorder—Stavudine—acquired immunodeficiency syndrome	0.000582	0.00382	CcSEcCtD
Chlorpropamide—Decreased appetite—Abacavir—acquired immunodeficiency syndrome	0.000577	0.00379	CcSEcCtD
Chlorpropamide—SLC15A2—blood—acquired immunodeficiency syndrome	0.000575	0.0202	CbGeAlD
Chlorpropamide—Thrombocytopenia—Zidovudine—acquired immunodeficiency syndrome	0.000573	0.00377	CcSEcCtD
Chlorpropamide—Gastrointestinal disorder—Abacavir—acquired immunodeficiency syndrome	0.000573	0.00377	CcSEcCtD
Chlorpropamide—Anorexia—Zidovudine—acquired immunodeficiency syndrome	0.000558	0.00367	CcSEcCtD
Chlorpropamide—Erythema multiforme—Lamivudine—acquired immunodeficiency syndrome	0.000556	0.00366	CcSEcCtD
Chlorpropamide—CYP2C19—blood—acquired immunodeficiency syndrome	0.000555	0.0195	CbGeAlD
Chlorpropamide—Urticaria—Nevirapine—acquired immunodeficiency syndrome	0.000554	0.00364	CcSEcCtD
Chlorpropamide—SLC15A2—spinal cord—acquired immunodeficiency syndrome	0.000554	0.0195	CbGeAlD
Chlorpropamide—Pruritus—Didanosine—acquired immunodeficiency syndrome	0.000549	0.00361	CcSEcCtD
Chlorpropamide—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.000541	0.00356	CcSEcCtD
Chlorpropamide—Leukopenia—Delavirdine—acquired immunodeficiency syndrome	0.00054	0.00355	CcSEcCtD
Chlorpropamide—Urticaria—Nelfinavir—acquired immunodeficiency syndrome	0.000537	0.00353	CcSEcCtD
Chlorpropamide—Rash—Amprenavir—acquired immunodeficiency syndrome	0.000537	0.00353	CcSEcCtD
Chlorpropamide—Urticaria—Stavudine—acquired immunodeficiency syndrome	0.000535	0.00352	CcSEcCtD
Chlorpropamide—Headache—Amprenavir—acquired immunodeficiency syndrome	0.000533	0.00351	CcSEcCtD
Chlorpropamide—SLC15A2—vagina—acquired immunodeficiency syndrome	0.000533	0.0187	CbGeAlD
Chlorpropamide—Thrombocytopenia—Indinavir—acquired immunodeficiency syndrome	0.000533	0.0035	CcSEcCtD
Chlorpropamide—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.000531	0.00349	CcSEcCtD
Chlorpropamide—Urticaria—Abacavir—acquired immunodeficiency syndrome	0.000527	0.00347	CcSEcCtD
Chlorpropamide—Anorexia—Indinavir—acquired immunodeficiency syndrome	0.000519	0.00341	CcSEcCtD
Chlorpropamide—Dyspepsia—Zidovudine—acquired immunodeficiency syndrome	0.000515	0.00339	CcSEcCtD
Chlorpropamide—PTGS1—skin of body—acquired immunodeficiency syndrome	0.000515	0.0181	CbGeAlD
Chlorpropamide—CYP2C19—vagina—acquired immunodeficiency syndrome	0.000514	0.0181	CbGeAlD
Chlorpropamide—Decreased appetite—Zidovudine—acquired immunodeficiency syndrome	0.000509	0.00335	CcSEcCtD
Chlorpropamide—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000506	0.00332	CcSEcCtD
Chlorpropamide—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.000506	0.00332	CcSEcCtD
Chlorpropamide—Gliclazide—ALB—acquired immunodeficiency syndrome	0.000505	0.461	CrCbGaD
Chlorpropamide—SLC15A2—lung—acquired immunodeficiency syndrome	0.000504	0.0177	CbGeAlD
Chlorpropamide—Thrombocytopenia—Efavirenz—acquired immunodeficiency syndrome	0.000504	0.00331	CcSEcCtD
Chlorpropamide—Leukopenia—Ritonavir—acquired immunodeficiency syndrome	0.000499	0.00328	CcSEcCtD
Chlorpropamide—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000494	0.00324	CcSEcCtD
Chlorpropamide—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000493	0.00324	CcSEcCtD
Chlorpropamide—Anorexia—Efavirenz—acquired immunodeficiency syndrome	0.00049	0.00322	CcSEcCtD
Chlorpropamide—Rash—Didanosine—acquired immunodeficiency syndrome	0.000489	0.00322	CcSEcCtD
Chlorpropamide—Headache—Didanosine—acquired immunodeficiency syndrome	0.000486	0.0032	CcSEcCtD
Chlorpropamide—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.000482	0.00317	CcSEcCtD
Chlorpropamide—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	0.000481	0.00316	CcSEcCtD
Chlorpropamide—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000479	0.00315	CcSEcCtD
Chlorpropamide—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000478	0.00314	CcSEcCtD
Chlorpropamide—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000477	0.00314	CcSEcCtD
Chlorpropamide—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000477	0.00313	CcSEcCtD
Chlorpropamide—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000473	0.00311	CcSEcCtD
Chlorpropamide—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.00047	0.00309	CcSEcCtD
Chlorpropamide—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.00047	0.00309	CcSEcCtD
Chlorpropamide—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000469	0.00308	CcSEcCtD
Chlorpropamide—SLC15A2—nervous system—acquired immunodeficiency syndrome	0.000467	0.0164	CbGeAlD
Chlorpropamide—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000465	0.00306	CcSEcCtD
Chlorpropamide—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000462	0.00304	CcSEcCtD
Chlorpropamide—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000461	0.00303	CcSEcCtD
Chlorpropamide—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000461	0.00303	CcSEcCtD
Chlorpropamide—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.000458	0.00301	CcSEcCtD
Chlorpropamide—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000454	0.00298	CcSEcCtD
Chlorpropamide—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000453	0.00298	CcSEcCtD
Chlorpropamide—CYP2C9—digestive system—acquired immunodeficiency syndrome	0.000452	0.0158	CbGeAlD
Chlorpropamide—SLC15A2—central nervous system—acquired immunodeficiency syndrome	0.00045	0.0158	CbGeAlD
Chlorpropamide—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000447	0.00294	CcSEcCtD
Chlorpropamide—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000447	0.00294	CcSEcCtD
Chlorpropamide—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000446	0.00293	CcSEcCtD
Chlorpropamide—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000446	0.00293	CcSEcCtD
Chlorpropamide—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000444	0.00292	CcSEcCtD
Chlorpropamide—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000444	0.00292	CcSEcCtD
Chlorpropamide—Rash—Nevirapine—acquired immunodeficiency syndrome	0.00044	0.00289	CcSEcCtD
Chlorpropamide—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000439	0.00288	CcSEcCtD
Chlorpropamide—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000437	0.00287	CcSEcCtD
Chlorpropamide—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000434	0.00285	CcSEcCtD
Chlorpropamide—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000433	0.00285	CcSEcCtD
Chlorpropamide—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000433	0.00284	CcSEcCtD
Chlorpropamide—CYP2C9—blood—acquired immunodeficiency syndrome	0.00043	0.0151	CbGeAlD
Chlorpropamide—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.00043	0.00282	CcSEcCtD
Chlorpropamide—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000429	0.00282	CcSEcCtD
Chlorpropamide—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000428	0.00282	CcSEcCtD
Chlorpropamide—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000428	0.00281	CcSEcCtD
Chlorpropamide—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000426	0.0028	CcSEcCtD
Chlorpropamide—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000425	0.00279	CcSEcCtD
Chlorpropamide—Rash—Stavudine—acquired immunodeficiency syndrome	0.000425	0.00279	CcSEcCtD
Chlorpropamide—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000423	0.00278	CcSEcCtD
Chlorpropamide—Headache—Stavudine—acquired immunodeficiency syndrome	0.000422	0.00277	CcSEcCtD
Chlorpropamide—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000422	0.00277	CcSEcCtD
Chlorpropamide—Rash—Abacavir—acquired immunodeficiency syndrome	0.000418	0.00275	CcSEcCtD
Chlorpropamide—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000418	0.00275	CcSEcCtD
Chlorpropamide—Headache—Abacavir—acquired immunodeficiency syndrome	0.000416	0.00273	CcSEcCtD
Chlorpropamide—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000414	0.00272	CcSEcCtD
Chlorpropamide—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000414	0.00272	CcSEcCtD
Chlorpropamide—PTGS1—digestive system—acquired immunodeficiency syndrome	0.000412	0.0145	CbGeAlD
Chlorpropamide—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000409	0.00269	CcSEcCtD
Chlorpropamide—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000409	0.00269	CcSEcCtD
Chlorpropamide—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000401	0.00264	CcSEcCtD
Chlorpropamide—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000401	0.00263	CcSEcCtD
Chlorpropamide—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000401	0.00263	CcSEcCtD
Chlorpropamide—Nausea—Stavudine—acquired immunodeficiency syndrome	0.0004	0.00263	CcSEcCtD
Chlorpropamide—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000398	0.00262	CcSEcCtD
Chlorpropamide—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000396	0.0026	CcSEcCtD
Chlorpropamide—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000394	0.00259	CcSEcCtD
Chlorpropamide—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000393	0.00258	CcSEcCtD
Chlorpropamide—PTGS1—blood—acquired immunodeficiency syndrome	0.000393	0.0138	CbGeAlD
Chlorpropamide—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000391	0.00257	CcSEcCtD
Chlorpropamide—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000387	0.00255	CcSEcCtD
Chlorpropamide—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000386	0.00254	CcSEcCtD
Chlorpropamide—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000385	0.00253	CcSEcCtD
Chlorpropamide—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000381	0.0025	CcSEcCtD
Chlorpropamide—PTGS1—spinal cord—acquired immunodeficiency syndrome	0.000378	0.0133	CbGeAlD
Chlorpropamide—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000378	0.00249	CcSEcCtD
Chlorpropamide—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000373	0.00245	CcSEcCtD
Chlorpropamide—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000372	0.00245	CcSEcCtD
Chlorpropamide—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000369	0.00243	CcSEcCtD
Chlorpropamide—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000368	0.00242	CcSEcCtD
Chlorpropamide—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000367	0.00241	CcSEcCtD
Chlorpropamide—PTGS1—vagina—acquired immunodeficiency syndrome	0.000364	0.0128	CbGeAlD
Chlorpropamide—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000364	0.00239	CcSEcCtD
Chlorpropamide—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000363	0.00239	CcSEcCtD
Chlorpropamide—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000362	0.00238	CcSEcCtD
Chlorpropamide—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000361	0.00237	CcSEcCtD
Chlorpropamide—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.00036	0.00237	CcSEcCtD
Chlorpropamide—SLC15A2—brain—acquired immunodeficiency syndrome	0.000357	0.0125	CbGeAlD
Chlorpropamide—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000352	0.00231	CcSEcCtD
Chlorpropamide—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000348	0.00229	CcSEcCtD
Chlorpropamide—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000348	0.00229	CcSEcCtD
Chlorpropamide—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000348	0.00229	CcSEcCtD
Chlorpropamide—ABCB1—retina—acquired immunodeficiency syndrome	0.000347	0.0122	CbGeAlD
Chlorpropamide—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000346	0.00228	CcSEcCtD
Chlorpropamide—SLC15A2—lymph node—acquired immunodeficiency syndrome	0.000345	0.0121	CbGeAlD
Chlorpropamide—PTGS1—lung—acquired immunodeficiency syndrome	0.000344	0.0121	CbGeAlD
Chlorpropamide—Rash—Indinavir—acquired immunodeficiency syndrome	0.000343	0.00226	CcSEcCtD
Chlorpropamide—Headache—Indinavir—acquired immunodeficiency syndrome	0.000341	0.00224	CcSEcCtD
Chlorpropamide—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.00034	0.00224	CcSEcCtD
Chlorpropamide—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000337	0.00221	CcSEcCtD
Chlorpropamide—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000332	0.00218	CcSEcCtD
Chlorpropamide—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000327	0.00215	CcSEcCtD
Chlorpropamide—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000326	0.00214	CcSEcCtD
Chlorpropamide—Probenecid—ALB—acquired immunodeficiency syndrome	0.000324	0.296	CrCbGaD
Chlorpropamide—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000324	0.00213	CcSEcCtD
Chlorpropamide—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000323	0.00213	CcSEcCtD
Chlorpropamide—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000322	0.00212	CcSEcCtD
Chlorpropamide—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000322	0.00212	CcSEcCtD
Chlorpropamide—PTGS1—nervous system—acquired immunodeficiency syndrome	0.000319	0.0112	CbGeAlD
Chlorpropamide—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000313	0.00206	CcSEcCtD
Chlorpropamide—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000312	0.00205	CcSEcCtD
Chlorpropamide—Rash—Delavirdine—acquired immunodeficiency syndrome	0.00031	0.00204	CcSEcCtD
Chlorpropamide—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.00031	0.00204	CcSEcCtD
Chlorpropamide—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000308	0.00203	CcSEcCtD
Chlorpropamide—PTGS1—central nervous system—acquired immunodeficiency syndrome	0.000307	0.0108	CbGeAlD
Chlorpropamide—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000306	0.00201	CcSEcCtD
Chlorpropamide—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000301	0.00198	CcSEcCtD
Chlorpropamide—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.0003	0.00197	CcSEcCtD
Chlorpropamide—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000296	0.00194	CcSEcCtD
Chlorpropamide—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000292	0.00192	CcSEcCtD
Chlorpropamide—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.00029	0.0019	CcSEcCtD
Chlorpropamide—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000289	0.0019	CcSEcCtD
Chlorpropamide—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000287	0.00189	CcSEcCtD
Chlorpropamide—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000286	0.00188	CcSEcCtD
Chlorpropamide—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000285	0.00187	CcSEcCtD
Chlorpropamide—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000279	0.00183	CcSEcCtD
Chlorpropamide—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000276	0.00182	CcSEcCtD
Chlorpropamide—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000276	0.00182	CcSEcCtD
Chlorpropamide—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000275	0.0018	CcSEcCtD
Chlorpropamide—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.00027	0.00178	CcSEcCtD
Chlorpropamide—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000266	0.00175	CcSEcCtD
Chlorpropamide—Glyburide—ALB—acquired immunodeficiency syndrome	0.000265	0.242	CrCbGaD
Chlorpropamide—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000264	0.00173	CcSEcCtD
Chlorpropamide—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000262	0.00172	CcSEcCtD
Chlorpropamide—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.00026	0.00171	CcSEcCtD
Chlorpropamide—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000248	0.00163	CcSEcCtD
Chlorpropamide—ABCB1—lymphoid tissue—acquired immunodeficiency syndrome	0.000247	0.00866	CbGeAlD
Chlorpropamide—ABCB1—digestive system—acquired immunodeficiency syndrome	0.000244	0.00855	CbGeAlD
Chlorpropamide—PTGS1—brain—acquired immunodeficiency syndrome	0.000244	0.00855	CbGeAlD
Chlorpropamide—PTGS1—lymph node—acquired immunodeficiency syndrome	0.000236	0.00826	CbGeAlD
Chlorpropamide—ABCB1—blood—acquired immunodeficiency syndrome	0.000232	0.00815	CbGeAlD
Chlorpropamide—ABCB1—bone marrow—acquired immunodeficiency syndrome	0.000225	0.00789	CbGeAlD
Chlorpropamide—ABCB1—spinal cord—acquired immunodeficiency syndrome	0.000224	0.00785	CbGeAlD
Chlorpropamide—ABCB1—vagina—acquired immunodeficiency syndrome	0.000215	0.00755	CbGeAlD
Chlorpropamide—ABCB1—lung—acquired immunodeficiency syndrome	0.000204	0.00714	CbGeAlD
Chlorpropamide—ABCB1—nervous system—acquired immunodeficiency syndrome	0.000189	0.00662	CbGeAlD
Chlorpropamide—ABCB1—central nervous system—acquired immunodeficiency syndrome	0.000182	0.00637	CbGeAlD
Chlorpropamide—ABCB1—brain—acquired immunodeficiency syndrome	0.000144	0.00506	CbGeAlD
Chlorpropamide—ABCB1—lymph node—acquired immunodeficiency syndrome	0.000139	0.00489	CbGeAlD
